GSK proposal for marketing Belimumab rejected by CDSCO panel Medical Dialogues Team8 July 2021 6:31 PM ISTNew Delhi: In a major setback to GlaxoSmithKline (GSK) Pharmaceuticals, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Lupin gets CDSCO committee approval for marketing Ranibizumab Medical Dialogues Team7 July 2021 5:03 PM ISTNew Delhi: In a major rejoice to drug maker Lupin, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Sun Pharma gets CDSCO panel nod for Teriparatide Injection Medical Dialogues Team6 July 2021 1:06 PM ISTNew Delhi: Pharmaceutical major, Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sun Pharma gets CDSCO panel ok for BE study of Sitagliptin, Metformin, Glimepiride FDC Medical Dialogues Team24 Jun 2021 4:52 PM ISTNew Delhi: Pharmaceutical major, Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Changes in design of Meril Life Sciences Myval Transcatheter Heart Valve approved by CDSCO panel Medical Dialogues Team23 Jun 2021 4:54 PM ISTNew Delhi: Approving the minor changes proposed by the Meril Life Sciences regarding the design of Myval Transcatheter Heart Valve (THV) and ballon...
Include cardiology parameters in clinical trial of anti diabetic drug Lobeglitazone: CDSCO panel tells Glenmark Medical Dialogues Team22 Jun 2021 2:54 PM ISTNew Delhi: In accordance with the proposal presented by pharma major, Glenmark, on the anti-diabetic drug molecule, Lobeglitazone Sulphate Tablets,...
Mankind Pharma gets CDSCO panel nod for trial of anti diabetic molecule, MKP10241 Medical Dialogues Team20 Jun 2021 10:00 AM ISTNew Delhi: Approving the Investigational New Drug (IND) application for Novel Anti Diabetic Molecule, MKP10241, the Subject Expert Committee (SEC) of...
Akums Drugs Montelukast Sodium, Bilastine FDC gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Jun 2021 11:15 AM ISTNew Delhi: The Subject Expert Committee functional under the Central Drugs Standard Control Organization (CDSCO) has given its clearance to Akums...
Lupin gets CDSCO panel nod for phase III trial of Formoterol Fumarate, Budesonide FDC Medical Dialogues Team17 Jun 2021 12:30 PM ISTNew Delhi: Pharmaceutical major, Lupin has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Glenmark gets CDSCO panel nod to revise phase 4 protocol for Minocycline Hydrochloride Topical Gel Medical Dialogues Team16 Jun 2021 9:30 AM ISTNew Delhi: Responding to the phase IV protocol for Minocycline Hydrochloride Topical Gel 4% for topical use presented by Glenmark Pharma, the Subject...
Exclude patients with history of TB from Baricitinib clinical study for Atopic Dermatitis: CDSCO panel tells Eli Lilly Medical Dialogues Team15 Jun 2021 4:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has asked Eli Lilly to conduct a...
CDSCO panel nod to phase 3 trials of Sputnik V by Hetero Pharma Medical Dialogues Team30 April 2021 3:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has given a green signal to Hetero...
